Key Highlights
- Tim Buckley, former Vanguard CEO, joins Pfizer’s Board of Directors.
- Buckley to serve on Governance & Sustainability and Audit Committees.
- Board now comprises 14 directors, 13 of whom are independent.
- Buckley’s leadership experience in investment and finance strengthens Pfizer’s governance.
Source: Business Wire
Notable Quotes
- “Tim is a widely respected business leader with deep expertise in global investment management, financial markets, and operations and someone who values a shared sense of purpose, all of which will be an asset to Pfizer and our shareholders.” — Albert Bourla, Chairman and CEO at Pfizer
- “I’m impressed with Pfizer’s dedication to patients and focus on innovation to improve health.” — Tim Buckley, Board Member at Pfizer
SoHC's Take
The appointment of Tim Buckley to Pfizer’s Board highlights the company’s strategic emphasis on strengthening financial oversight and corporate governance. With Buckley’s extensive experience in managing large-scale investment operations and understanding of financial markets, Pfizer stands to benefit from his insights, especially as it continues to drive innovation in healthcare and maximize shareholder value. His background in leadership at Vanguard and his commitment to public service add further credibility to Pfizer’s mission of transforming patient care through innovation.
